Morgan Stanley Immuno Precise Antibodies Ltd. Transaction History
Morgan Stanley
- $1.35 Trillion
- Q3 2024
A detailed history of Morgan Stanley transactions in Immuno Precise Antibodies Ltd. stock. As of the latest transaction made, Morgan Stanley holds 12,533 shares of IPA stock, worth $7,269. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,533
Previous 10,533
18.99%
Holding current value
$7,269
Previous $10,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding IPA
# of Institutions
19Shares Held
1.9MCall Options Held
0Put Options Held
0-
Ingalls & Snyder LLC New York, NY1.56MShares$904,1570.04% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny60.3KShares$34,9740.0% of portfolio
-
Bank Of Montreal Toronto, A657.8KShares$33,5280.0% of portfolio
-
Northern Trust Corp Chicago, IL50.7KShares$29,4230.0% of portfolio
-
Cibc World Market Inc. Toronto, A641.2KShares$23,8960.0% of portfolio
About ImmunoPrecise Antibodies Ltd.
- Ticker IPA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,836,700
- Market Cap $14.4M
- Description
- ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...